News

The recombinant humanized monoclonal antibody nimotuzumab is developed to target the epidermal growth factor receptor (EGFR). The multicenter, randomized phase 3 trial for lung cancer will enroll around

The office is located at the Cambridge Innovation Center that is located on Kendall Square. BioOutsource CEO Gerry MacKay said the new office, which is the first one

The company plans to shut down the plant in May 2013 for a few weeks. Lonza provides products and services covering research to final product manufacturing needs of

The company has named Dr. Rob Koremans as the president and CEO of Global Specialty Medicines. Koremans will report to Teva Pharmaceutical Industries president and CEO Dr. Jeremy

Galderma has worldwide marketing rights for Nuvo’s Pliaglis, a topical local anesthetic cream indicated for the production of local dermal anaesthesia preceding dermatological procedures in adults. Pliaglis leverages

The patent alleges a metered valve pump spray device comprising a liquid cannabis extract, in propylene glycol and ethanol, which is adapted to spray a dose towards a

Civil fraud lawsuit claimed that Novartis had disguised kickbacks as performance rebates and discounts to encourage pharmacies to oppose the use of cheaper, generic drugs or competitor drugs.

Quarterly turnover was £6.47bn, down from restated £6.64bn for the same period last year. GSK delivered core EPS of 26.9pence and dividend of 18pence for the first quarter

BioCarrier cases will provide regular route, multiple site sample collection and "home visit" temperature-sensitive injectable drug protection. Intelsius CEO David Walsh said that the company is introducing the